Table 2 Socio-demographics and clinical characteristics between MDD comorbid ATF with and without abnormal glucose
Variable | MDD comorbid ATF | F, Z or χ2 | P | |
|---|---|---|---|---|
With abnormal glucose (n = 494) | Without abnormal glucose (n = 550) | |||
Male, n (%) | 158(32.0) | 200(36.4) | 2.026 | 0.137 |
Education, n (%) | 1.663 | 0.645 | ||
1 | 131(26.5) | 132(24.0) | ||
2 | 213(43.1) | 238(43.3) | ||
3 | 124(25.1) | 143(26.0) | ||
4 | 26(5.3) | 37(6.7) | ||
Marry status, n (%) | 355(71.9) | 405(73.6) | 0.33 | 0.566 |
Suicide, n (%) | 156(31.6) | 107(19.5) | 19.66 | < 0.001 |
Severe anxiety, n (%) | 90(18.2) | 70(12.7) | 5.63 | 0.018 |
Exhibiting psychotic symptoms, n (%) | 81(16.4) | 55(10.0) | 8.84 | 0.003 |
Actual age, year | 35.76(12.57) | 35.61(12.30) | 0.33 | 0.855 |
Duration of disease, month | 7.06(4.57) | 6.95(5.09) | 0.13 | 0.715 |
Age of onset, year | 35.51(12.43) | 35.38(12.16) | 0.03 | 0.862 |
Actual age group | 0.75 | 0.69 | ||
18–39 years, n (%) | 280 (56.7) | 325 (59.1) | ||
40–49 years, n (%) | 132 (26.7) | 135 (24.5) | ||
≥ 50 years, n (%) | 82 (16.6) | 90 (16.4) | ||
HAMD | 31.65(2.62) | 30.85(2.74) | 22.88 | < 0.001 |
HAMA | 21.66(3.70) | 20.74(3.52) | 16.77 | < 0.001 |
PANSS | 10.02(5.45) | 8.97(4.39) | 11.72 | 0.001 |
TSH, mIU/L | 7.18(1.95) | 6.23(1.65) | 72.33 | < 0.001 |
A-TG, IU/Ml | 23.1(15.9,115.4) | 22.5(14.9,60.2) | -1.18 | 0.237 |
A-TPO, IU/Ml | 22.3(12.9,94.9) | 19.7(12.4,44.7) | -3.26 | 0.001 |
FT3, pg/mL | 4.91(0.73) | 4.93(0.75) | 0.24 | 0.625 |
FT4, ng/dL | 16.64(3.09) | 16.67(3.13) | 0.02 | 0.885 |
BMI, kg/m 2 | 24.58(1.99) | 24.66(1.94) | 0.44 | 0.507 |